TP53 and central nervous system cancer: In contrast, for TP53 Arg72-Pro, the CC genotype was associated with a significantly increased risk of glioma compared to the GG genotype (CC vs. GG: OR = 1.73; 95% CI, 1.04–2.89, P = 0.04).